144 related articles for article (PubMed ID: 34758491)
1. Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis.
Vestito A; Dajti E; Cortellini F; Montagnani M; Bazzoli F; Zagari RM
Ultraschall Med; 2023 Jun; 44(3):e139-e147. PubMed ID: 34758491
[TBL] [Abstract][Full Text] [Related]
2. Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation.
Lee YR; Park SY; Kim SU; Jang SY; Tak WY; Kweon YO; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Hur K
J Gastroenterol Hepatol; 2017 May; 32(5):1079-1086. PubMed ID: 27859615
[TBL] [Abstract][Full Text] [Related]
3. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
Cho HJ; Kim B; Kim HJ; Huh J; Kim JK; Lee JH; Seo CW; Ahn HR; Eun JW; Kim SS; Cho SW; Cheong JY
Eur Radiol; 2020 Aug; 30(8):4182-4192. PubMed ID: 32189053
[TBL] [Abstract][Full Text] [Related]
4. Comparison of acoustic radiation force impulse elastography and transient elastography for prediction of hepatocellular carcinoma recurrence after radiofrequency ablation.
Yoon JS; Lee YR; Kweon YO; Tak WY; Jang SY; Park SY; Hur K; Park JG; Lee HW; Chun JM; Han YS; Lee WK
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1230-1236. PubMed ID: 29794814
[TBL] [Abstract][Full Text] [Related]
5. Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation.
Lee PC; Chiou YY; Chiu NC; Chen PH; Liu CA; Kao WY; Huo TI; Huang YH; Hou MC; Lin HC; Wu JC; Su CW
Sci Rep; 2020 Feb; 10(1):2006. PubMed ID: 32029840
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
[TBL] [Abstract][Full Text] [Related]
7. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study.
Han X; Dong J; Liu Z; Wu B; Tian Y; Tan H; Cheng W
Int J Hyperthermia; 2020; 37(1):1066-1073. PubMed ID: 32924654
[TBL] [Abstract][Full Text] [Related]
8. Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
Yang Y; Yu H; Tan X; You Y; Liu F; Zhao T; Qi J; Li J; Feng Y; Zhu Q
Int J Hyperthermia; 2021; 38(1):875-886. PubMed ID: 34078221
[TBL] [Abstract][Full Text] [Related]
9. Can "no-touch" radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis.
Kim TH; Lee JM; Lee DH; Joo I; Park SJ; Yoon JH
Eur Radiol; 2023 Jan; 33(1):545-554. PubMed ID: 35907024
[TBL] [Abstract][Full Text] [Related]
10. Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma.
Lee SH; Kim SU; Jang JW; Bae SH; Lee S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Onco Targets Ther; 2015; 8():347-56. PubMed ID: 25678801
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement: are they at risk of HCC recurrence after ablation or surgery? A systematic review and meta-analysis.
Kim TH; Woo S; Han S; Suh CH; Lee DH; Lee JM
Eur Radiol; 2020 Mar; 30(3):1624-1633. PubMed ID: 31776747
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis.
Jin S; Tan S; Peng W; Jiang Y; Luo C
World J Surg Oncol; 2020 Aug; 18(1):199. PubMed ID: 32787883
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.
Tiong L; Maddern GJ
Br J Surg; 2011 Sep; 98(9):1210-24. PubMed ID: 21766289
[TBL] [Abstract][Full Text] [Related]
14. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma.
Yoon JH; Goo YJ; Lim CJ; Choi SK; Cho SB; Shin SS; Jun CH
World J Gastroenterol; 2020 Aug; 26(32):4833-4845. PubMed ID: 32921960
[TBL] [Abstract][Full Text] [Related]
15. One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma.
Barat M; Fohlen A; Cassinotto C; Jannot AS; Dautry R; Pelage JP; Boudiaf M; Pocard M; Eveno C; Taouli B; Soyer P; Dohan A
J Magn Reson Imaging; 2017 Jun; 45(6):1648-1658. PubMed ID: 27766709
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis.
Dong W; Zhang T; Wang ZG; Liu H
World J Gastroenterol; 2014 Aug; 20(29):10174-82. PubMed ID: 25110446
[TBL] [Abstract][Full Text] [Related]
17. Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
Gupta P; Maralakunte M; Kumar-M P; Chandel K; Chaluvashetty SB; Bhujade H; Kalra N; Sandhu MS
Eur Radiol; 2021 Jul; 31(7):5400-5408. PubMed ID: 33439319
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis.
Zhang Y; Chen H; Chen S; Li W
Int J Hyperthermia; 2021; 38(1):1052-1059. PubMed ID: 34251953
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance.
Cao S; Lyu T; Fan Z; Guan H; Song L; Tong X; Wang J; Zou Y
Cancer Imaging; 2022 Jan; 22(1):2. PubMed ID: 34983650
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
